SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-016804
Filing Date
2023-03-07
Accepted
2023-03-07 16:52:04
Documents
2
Period of Report
2023-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 10499
2 POA DOCUMENT poa.txt EX-24 3765
  Complete submission text file 0001209191-23-016804.txt   15728
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Issuer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SUTRO BIOPHARMA, INC. 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
Shtylla Brunilda (Reporting) CIK: 0001966915 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38662 | Film No.: 23713325